15th European Molecular Imaging Meeting
supported by:

To search for a specific ID please enter the hash sign followed by the ID number (e.g. #123).
Keyword Contributions
11c-methylation 113
13c -labeled tracer 137
13c mrs PS 23-03
13c nmr PS 23-03
18f PS 05-04
18f-difluoromethylation 127
18f-fdg PS 08-02
18f-fdg pet 128
18f-fdg pet/mri 100
18f-fdg-pet PS 06-04
18f-fluoronaphthol PS 21-07
18f-flurolactate PS 08-02
18f-fmiso PS 08-07
18f-labelled tracers 115
18f-naf 104
18f-psma-11 100
18f-sodium fluoride 135
19f PS 08-04107
19f mri PS 08-04PS 08-04107134
19f mri inflammation imaging 105
19f stem cell tracking 130
19f-cest 134
19f-icest 134
19f-mri PS 08-04126130
2-nitroimidazole 119
2h fumarate PL 08-10-01
2k1c 135
31p magnetic resonance imaging 107
31p magnetic resonance spectroscopy 107
3d 137
3d image registation 138
3d imaging PS 20-05
3d live imaging 118
3d live tracking. 139
3r 117
5-ht1a receptors PS 23-02
52-mn #92
5d ct PS 02-02
5xfad 128
62zn PS 05-04
68ga #40131
68ga-dkfz-psma-11 113
68ga-dota-cdp1 131
68gadfo 131
89zr PS 09-07
90y-dota-psma-d4 138
99mtc-mibi 115
99mtc-radiotracer 119119
[11c]ucb-j 129
[18f]cf4 PS 08-03
[18f]cinacalcet 113
[18f]dpa-714 pet PS 21-03
[18f]faza 120
[18f]flt pet 120
[18f]fluda 127130
[18f]fluoroform 113
[18f]fluorothymidine 104
[18f]frpg PS 08-07
[18f]fspg PS 08-07
[18f]ge180 PS 21-03
[18f]psma-1007 100
[68ga]-ubi 131
a2ar 130
abdominal aortic aneurysm PS 08-06104
abdominal wall recurrence 133
absorbable sutures 104
accurate measurement 115
acetazolamide 127
acetylcholine PS 23-02
acini PS 08-06
acoustic microscopy PS 08-06
acquatic animal imaging 135
acute cardiomyopathy induced by stress 130
acute respiratory distress syndrome PS 21-02
adenosine 130
adenosine 2a receptor 102
adenosine a2a receptor 127
adept 134
administration routes 135
adoptive t cell therapy PS 23-05
advanced microscopy 103
affibody PS 23-05
aging 138
aif PS 08-03
akt1 kinase 131
alf-18 113
alk5 PS 23-04
allergic asthma 105
alpha-synuclein 129
als 128
alternativ animal model PS 21-07
alzheimer PS 08-03
alzheimer disease model 102
alzheimer model 102
alzheimer' disease 129
alzheimer's disease PS 01-06PS 09-03102127
alzheimer's mouse model 128
alzheimer’s disease PS 09-03
ambroxol 128
amino acids 119
amphipathic peptide 126
amphotericin b PS 05-05114
amyloid PS 01-06116
amyloid beta 128
amyloid plaques PS 09-03
amyloid-beta PS 09-03129
anesthesia PS 23-02PS 23-03116
aneuploidy PL 08-10-02
angiogenesis 114137
angiography 129
angiotensin ii 104
animal PL 08-10-02
animal model PS 01-06PL 08-10-01130
animal study 138
annexin a5 113
anthracyclines 130
anti-cancer agents 138
anti-cancer drug 101
antibiocs PS 05-07
antibiotics PS 05-05
antibody PS 05-07PS 05-07PL 08-10-03100132
antibody labelling 136
antibody modification PL 08-10-03
anticancer 135
antitumor metal complexes 106134
aortic dissection 104
apoe-/- 104
apoptosis PS 06-03126
aptamer PS 09-02
aptamers 118
arftificial intelligence PS 08-06
arterial input function 103
arterial tacs 135
arthritis 117
artifacts 137
ascending aorta aneurysms 104
asthma mouse model 116
astrocytes 128
asymmetric radiosynthesis 119
atherosclerosis PS 23-04PS 23-04PS 08-04#40104104104104105
atherosclerotic plaque 105
atlas creation 103
atlas registration 118
au nanocluster 114
auditory processing PS 08-03
auger electrons 125
auto-regressive model PS 08-06
autoimmune-diseases 105
automation 135
autoradiography PS 01-06
avb6 101
axilla 100
axr 137
aza-bodipy 132
azd2461 100
azd3965 PS 08-02
baboons PS 05-07
background correction PS 08-06
backscattering PL 08-10-03
bacterial infection PS 05-07
barrel PS 21-03
barrett's oesophagus PS 09-07
barrett’s esophagus PS 09-07
basal cell carcinoma PL 08-10-02
basal forebrain cholinergic system PS 23-02
bbb PS 09-02
beam hardening 116
behavior 118139
bevacizumab PS 06-03
bevacizumab-800cw PS 09-07
biased agonist PS 23-02
bicuspid aortic valve 104
bimodal PS 08-02
bimodal imaging 132132
bimodal mri/pet #92
bimodality 106106
binding assay 118
bioconjugation PS 05-04
biodistribution 100113118129135
bioimaging 113114114136
bioluminescence imaging 138
biomarker PL 08-10-01PS 05-03133137
biomarkers 100
biomaterials 135
biotin 118
birch pollen 105
bispidine #92
bladder segmentation 100
bleomycin 116
blood brain barrier 128
blood flow PS 05-07
blood half-life 113
blood pressure radiotelemetry 132
blood vessels permeability 137
blood-brain barrier 129
bodipy PS 06-05
body imaging 137
bold oscillations 103
bone defect healing 135
bone formation 105
bone metastases PL 08-10-03
bone metastasis PS 23-05
bone model PS 09-07
boron vectorization 101
brain PS 05-07PS 06-04102129
brain atlas 103127
brain cancer 120
brain imaging PS 05-04
brain inflammation 103
brain perfusion PS 05-07
brain slice 103
brain tumor PS 08-03
brain tumors 113
brain-targeted delivery system 113
brainstate 127
breast cancer PS 20-05PS 23-05PS 06-03PL 08-10-02100117
breast imaging 117
breast tissue cancer 100
brown adipose tissue PS 06-04
bssfp 137
burst suppression PS 23-02
c. elegans 138
calcification PS 05-04PS 23-04104
calcifications PS 21-03
calcium PS 23-04PS 08-04
calcium fluoreescence imaging 128
calcium imaging PS 09-03103
calibration 118
cancer PS 22-05PS 05-03PS 05-03100100118126132133PS 24-02
cancer cell spheroids 138
cancer imaging PS 08-07126
cancer immunotherapy PS 05-03
cancer surgery 138
cancer targets PL 08-10-03
cancer therapy 101125
candida albicans 131
caps camera PS 23-07
carbon monoxide #127
carbon-11 113119
carbonic anhydrase ix PS 08-07
carcinoma gall bladder 133
cardiac 106
cardiac imaging PS 21-02
cardiac mri 133
cardioavascular diseases PS 23-04
cardiomyopathy PS 23-04
cardiotoxicity 130
cardiovascular 113
cardiovascular disease 104113
cardiovascular diseases 133
cardiovascular imaging 130
carotid 104
carotid artery 139
carotid atherosclerosis 104
cd11b 126
cd4 t cells PS 05-03
cd47 126
cd8 PS 21-07
cd80 PS 23-05
cea 132
cell death PS 06-03
cell labelling 113
cell therapy 106128
cell tracking PS 06-05106106134
cell-penetrating peptides PL 08-10-03
cerebral blood flow 102
cerebral ischemia PS 08-03PS 09-03
cerebral malaria PS 05-07
cerebral metabolic glucose rate 103
cerebral metabolism PS 23-03
cerebrovascular PS 09-03
cerenkov imaging PS 08-07136
cerenkov luminescence imaging 138
cerenkov luminescence imaging (cli) 138
cest PS 06-04107118134
cest quantification 118
cest-mri 118
chelation 135
chelator-free radiolabelling 113
chemical delivery system 113
chemistry PS 05-04
chemo-phototherapy 125
chemokines PS 22-05
chemoresistance 101
chemosensitivity PL 08-10-02
chemotherapeutics 138
chemotherapy 101
choline metabolism 133
chronic pain 128
chronic stage 128
cisplatin PL 08-10-03PL 08-10-02125
classification study 100
clemastine 127
click chemistry PL 08-10-03PL 08-10-03
click-chemistry PS 21-07
clinical ct 116
clinical isolates 130
clinical translation PS 06-03
clinical trial PS 23-07PS 06-03
clinical trials PS 09-07132
clustering 118
cmr 130
cochlea 103
coincidence time resolution 115
collagen based scaffold 129
collagen organization 129
colon cancer PS 08-02118120
colorectal cancer PS 06-03125
colorectal cancer subtypes PS 05-03
companion diagnostics PS 06-03
compartment modelling 100
compton camera PS 08-03
computed tomography PS 05-05PS 02-02
computer-assisted image interpretation 118
computer-assisted image processing 118
cone trajectory PS 23-03
confocal 120
confocal fluorescence imaging 136
congenital hyperinsulinism 133
conjugated polymer nanoparticles 114114114136
conjugation 136
connexin 127
contrast agent PS 21-07#303100105106107114
contrast agents PS 23-04PS 08-04101116116116134
contrast enhanced ultrasound 125
contrast media PS 21-02
contrast-enhanced computer tomography 116
contrast-enhanced ct 118
contrast-enhanced ultrasound imaging PS 06-05
copper trafficking PL 08-10-02
copper-64 PL 08-10-02
core-shell particles 136
core-shell structures 106
corioallantoic membrane 137
coronary arteries PS 21-02
cpg2 134
crc mouse models PS 05-03
crc stratification PS 05-03
crispr/cas9 PL 08-10-01
croconaine nanoparticles PS 08-03
crohn's disease PS 08-03
csf 127127
csf-1r PS 23-05PS 21-03
ct PS 01-06PS 21-07
ct filters 118
ct imaging 116
ct-fmt imaging 120
cu-64 PL 08-10-03
cuprizone 127
curprizone 102
cyanine dyes 113
cyanine-graphene hybrids 136
cyanines 114
d2 receptor PS 23-02127
darpins 125
data analysis PL 08-10-02
data filtering 118
data processing 118
data quantification PS 08-06
dce 118
dce-mri 101102
ddnp PS 23-03
deconvolution 118
deep learning PS 08-06118
deep learning for ct PS 02-02
default mode network PS 23-02
demyelination 102127
dendrimer PL 08-10-03
density 102
depression 103
desferrioxamine b 131
desferrioxamine derivative PS 05-04
desi PS 06-04
deuterium PS 05-03PS 06-04
deuterium metabolic imaging PL 08-10-01
deuterium mrs 133
dfo* PS 09-07
diabetes 118
diagnosis 100
differentiation 100
diffusion 137
dimeric pesin conjugates #84
diphosphine-peptide 135
disorder strength PL 08-10-03
dispersion PS 08-03
distraction osteogenesis 133
dna damage 130
dnp PS 06-04
dominant follicle selection 137
donepezil 127128
dopamine PL 08-10-01
dopamine receptors expression changes PL 08-10-01
dopaminergic system 127
dosimetry 118118
dota 113129
down syndrome 104128
doxorubicin 125129
dp1tyb model 128
dpa-714 PS 23-05
dpet-ct 135
dreadds PS 23-02
drug delivery particles 138
drug efficiency evaluation 138
drug release PS 06-05
drugs-lipiodol emulsions 106
dti 102128
dual labeling PS 23-07
dual-labeling #151
dw-mri 120
dwarf shrimp 118138139
dwi 133
dyes PS 09-02
dynamic acquisition 120
dynamic functional connectivity 102
dynamic imaging PS 01-07
dynamic pet 103
dynamic-contrast-enhanced (dce) 107
eae nhp 129
early bladder tumour detection 100
early detection PS 09-07
egcg modulation 104
egfr PS 23-05100119
el4 137
elastin-derived peptides PS 08-02
electrophysiology PS 23-02
elemental imaging PS 05-05
embolization 104
embryo 133
emerging countries 104
emi-137 PS 23-07
emsot PS 06-03
endocarditis 130
endoscopy PS 23-07PS 09-07125
enhanced permeability and retention (epr) effect 125
enzyme activity 133
enzyme imaging 133
enzyme responsive mri contrast agent 134
eosinophilic inflammation 105
epcam 125
epilepsy PS 08-03PS 21-03129
episc 130
epr 137
epr effect PL 08-10-03PL 08-10-02
epr imaging 119
epri in vivo 119
esophageal cancer PS 09-07125
esophageal carcinoma PS 09-07
ex vivo PS 23-07129
ex vivo biodistribution 105
exchange 137
exendin PS 09-07133
exfoliated graphene 136
exosomes 103129
experimental autoimmune myocarditis 130
extracellular lactate PS 06-04
extracellular matrix 107
f-18 135
fap PS 21-07
fast 3d epri 119
fat correction 118
fat deposition 138
fatty acid 114
fbp PS 01-03
fcfm PS 05-07
fdg 105135
fdg pet 130133
fdg pet/ct 133
feline oral squamous cell carcinoma 125
ferritin crystals 120
ferrocene derivatives 101
ferroptosis 120
fexi 137
fibril orientation 129
fibroblast PS 21-07
fibroblast activation protein PS 06-03
fibrosis PS 23-04139
figure making PL 08-10-02
fish 139
fkbp12-ryr stabilizer 135
flexivent 105
fli PS 08-07
flim 138
flt-ct PS 05-05
fluorescein 107
fluorescein angiography 103
fluorescence PS 23-07PS 23-07PS 06-05100104114114125132136
fluorescence imaging PS 04-05
fluorescence guided surgery 132
fluorescence image-guided surgery PS 05-03132
fluorescence imaging PS 05-05PS 08-04PS 08-02138
fluorescence life-time imaging 139
fluorescence lifetime PS 23-07
fluorescence microscopy PS 09-03120131
fluorescence molecular tomography 139
fluorescence monitoring 136
fluorescence tomography 138
fluorescence-guided surgery PS 23-07PS 23-07PS 08-02
fluorescent dyes #84
fluorescent guided surgery 132
fluorescent imaging PL 08-10-02
fluorescent molecular imaging 100
fluorescent organic nanoparticles 114
fluorescent platform 106
fluorescent probes 114136
fluorescent probes for in vivo in real-time imaging 126
fluorescent proteins 131
fluorescent tracer 136
fluorine magnetic resonance imaging 130
fluorine-18 PL 08-10-03119127
fluorogenic peptide 126
fluorophores 132
fmn 107
fmri PS 23-02PS 23-02PS 08-03PS 09-03PS 09-03103118127
focused rf heating PS 23-03
focussed ultrasound PS 09-02
formaldehyde 136
free flap monitoring 138
fret 114136
fugene 106
full-wave inversion 117
fumarate PS 23-03
functional connectivity PS 23-02103128
functional imaging 117
functional mri PS 08-03137
functional networks 102
functional ultrasound 103103127
functional ultrasound imaging PS 23-02
fungal biofilm 114
fungal infection 114
fungal infection model 131
fungal infections 131
furimazine PS 08-02
fus PS 21-03
gadolinium 107
gadolinium retention 107
gadovist 107
galectin-3 PS 05-03101
gallium-68 PS 05-04PS 08-07PS 08-02119128131
gallium‐68 131
gangliosides PS 09-03
gastrin-releasing peptide receptor 119
gastrointestinal PS 05-05105
gbm PS 06-04
gcamp 103
gcp ii ligands PL 08-10-02
gd(dota) nanoconstructs 134
gd-aaztac17 134
gd-conjugated capsules 134
gdept PS 08-07
genetic reporter systems 105
gfr 135
giant 134
glial cells PS 01-06
glioblastoma PS 23-05120125126133
glioma PS 23-05
glp-1 receptor PS 09-07133
glucose PS 23-03
glucose metabolism 129
glutamine PS 06-03
glutathione 114
glymphatic 127127
glymphatic system 102
gold nanoclusters PS 05-05
gold nanoparticles 101118125138
gold-shell nps 106
good manufacturing practice 113
graphene oxide 135
group beta streptococcus (gbs) 131
grpr 100
grpr-antagonist 119
gszs 107
gvhd 105
h69 xenograft 101
halotag 129
hcc PS 21-07
head and neck cancer 125
heart 130
heart failure PS 23-04
hemodynamics 133
hemoglobin 133
hepatitis 105
heptamethinecyanine fluorescent dyes 136
her2 PS 18-06
her3 PS 18-06
het-cam 119
hetcam 119
heterocyclic-substituted bodipy derivatives 136
hgsoc PS 05-03
high field 137
high field mr 107
high field mri 107
high field strength 137
high penetration depth PS 08-03
high rate pet PS 21-02
high resolution mri 137
high temporal resolution 137
high throughput imaging 118
histology PS 08-02
hne 136
hnis 115
hormones PS 08-03
hounsfield units 118
hpdo3a 107
human carotid artery PS 23-04
human skin 138
humanized fab PS 05-03101
huntington's disease PL 08-10-01102
hybrid 139
hybrid imaging PS 01-03
hybrid pixel detector PS 08-03
hydroxypyridinone 113
hypercapnia 137
hyperglycemia 128
hyperoxia 137
hyperpolarization PS 06-04PS 06-04PS 23-03107133
hyperpolarized PS 23-03
hyperpolarized 13c 133137
hyperpolarized mrsi 137
hyperpolarized nmr 137
hyperspectral PS 05-05
hypertension 132
hyperthermia 101
hypoparathyroidism 118
hypoxia PS 08-07117119
ibca 134
idiopathic lung diseases PS 05-05
il-6 127
illumination pattern PS 05-05
image analysis 120
image derive arterial input function 139
image fusion PS 01-03
image mass cytometry 120
image processing PS 08-06118
image reconstruction PS 05-05116139
image registration 118
image-guided drug delivery PS 06-03125134
imaging PS 05-03PS 05-03PS 23-03PS 23-03PL 08-10-03106117125131
imaging biomarkers PS 06-03PS 06-03
imaging guided biodistribution 128
imaging probes 134136
imaging processing PS 05-05
imaging tumour cell death PL 08-10-01
imatinib 104
immnopet 126
immune cell imaging 105130
immune checkpoint pathway 136
immune inflammation 105
immune-cell targeting PS 21-07
immuno-oncology PS 22-02
immuno-pet PS 05-04PS 09-07PL 08-10-03#631
immunocompetent models 126
immunofluorescence #634
immunology PS 09-02
immunomodulation PS 21-03
immunopet PS 05-03PS 05-07#151
immunotherapy PS 20-05PS 09-07126
implant 137
implanted nmr microcoil PS 23-03
imultaneous pet/ct-uui system PS 21-02
in ovo 119
in silico modeling 120
in vitro 131
in vivo PS 09-07107115135
in vivo bioluminescence 131
in vivo cell tracking 138
in vivo clearance 138
in vivo confocal 131
in vivo fluorescence imaging 138138
in vivo imaging PS 05-04138
in vivo micro-computed tomography 105
in vivo micropet 105
in vivo spectral unmixing 138
in vivo two-photon 131
in-loop 113
in-vivo PS 08-04132
in-vivo imaging PS 21-02
indium-111 106
indocyanine green PS 06-05118132132
infection PS 05-07PS 08-02131
infection imaging 130131131
infectious diseases 131
inflammation PS 06-04PS 23-04PS 23-04PS 08-04PS 21-07PS 21-07PS 09-02102105105130136138
inflammation imaging 130
inflammatory diseases 133
innate immunity PS 21-07
insulinoma PS 09-07
integrin αvβ6 120
integrins 101
interness 107
interrater reliability 100
interstitial-illumination PS 09-02
intra-operative imaging PS 05-03PS 23-07PS 23-07132
intranuclear PL 08-10-03
intraoperative PS 23-07PS 23-07
intraoperative imaging PS 05-03
intraperitoneal kainic acid rat model 102
intraperitoneal tumor model 132
intravital microscopy PS 23-05PS 21-07
intravital multiphoton microscopy PS 23-05
invasive pulmonary aspergillosis 131
inversion recovery 129
iododifunisal 128
ionizing radiation 130
ipsc-nps 128
ir800 dye 132
irdye800cw conjugation 114
iron metabolism 120
iron oxide nanoparticles 107120
ischemia 129
ischemia-reperfusion PS 21-03
ischemic stroke 102102
ivis 138
kem 118
ketones PS 05-03
kidney 137
kinetic modeling PS 06-04103
kisspeptin 129
kit-based infection imaging 131
kp46 101
l-cysteine PL 08-10-02
l-dopa induced dyskinesia PS 23-02
la-icp-ms PS 23-04
label-free PS 23-04
label-free molecular imaging PS 22-06
labeling PS 06-05126
lanthanide complex 107
lanthanide complexes 134
laparoscopic cholecystectomy 133
large stokes shift PS 06-05
large vessel vasculitis 104
laser speckle contrast imaging 132
laser spectroscopy PS 05-05
lc3 associated phagocytosis (lap) 131
ldl 134
led 117
leucine 102
life-threatening bleeding 104
lifetime of fluorescence 138
light sheet 138
light sheet fluorescence microscopy 125138
light sheet microscopy 138
light-triggered drug delivery #127
line scanning PS 09-03
lipid PS 23-04
lipid metabolism 133
lipids PS 08-03PS 09-03PL 08-10-02
liposome labelling 113
liposomes PS 09-02134135
live cell confocal microscopy 101
live-cell PS 22-06
liver PS 09-02138138
ln complexes 106
localistion 129
longitudinal in vivo micro-computed tomography 104
lorentzian fitting 118
low count imaging 115
low dose imaging PS 01-07
low molecular iron(iii)-complex-based contrast agents 134
lps PS 08-03105
lsfm 120138138
luciferin dose boost 131
luminescence 106
lung PS 08-06
lung ct PS 21-02
lung fibrosis 116
lung imaging 116139
lung inflammation and fibrosis 105
lung ventilation PS 08-03
lymph node imaging 100
lymph node staging PS 09-07
lymphadenectomy PS 05-03
macaca fascicularis 127
machine learning PS 05-03PS 08-07PS 08-06118128
maco 128
macrophage PS 22-02130
macrophage mannose receptor 126
macrophage mannose receptor (mmr) 126
macrophage polarization 120
macrophage profiling 126
macrophages 126126130
magnetic particle imaging 126
magnetic resonance fingerprinting 137
magnetic resonance imaging PS 19-03PS 21-03102107128134
magnetic resonance spectroscopy PS 06-04128
magnetization transfer contrast 134
malaria PS 05-07
maldi PS 08-03133
maldi-msi PS 23-04100
malignant melanoma PL 08-10-02
manganese PS 23-04#92107
manganese complexes 134
manganese ferrite 106
manganese-52 113
mannose receptor PS 05-03
maps PL 08-10-02
mass spectrometry imaging PS 06-04PS 09-03103
material decomposition 116
mc1 receptor 114
mct1 PS 08-02
mcts 138
mdsc 126
mdsfr/sff spectroscopy 118
mechanical force 120
mechanical ventilation PS 08-06
medical imaging PS 05-04
medium-sized animal spect 115
melanin 139
melanocytic nevi PL 08-10-02
melanoma PS 08-06PL 08-10-03100114
mesenchymal stem cells 129
mesoporous silica nanoparticles PS 06-05
metabolic PS 05-03
metabolic changes 128
metabolic disease 133
metabolic imaging PL 08-10-01133138
metabolic profiling PS 23-03
metabolism PS 05-03PS 06-04PS 06-04PS 06-04PS 23-03PS 23-03133PS 24-02
metal airborne particles PS 05-05
metal deposition 113
metal doping 107
metallomics PS 05-04
metastases 120
mhtt PL 08-10-01
micro-ct PS 21-02PL 08-10-03116116
microalgae radiolabelling 135
microbubbles PS 05-03#127
microct PS 01-06116118118139
microct imaging 116130
microfluidics PS 08-04113
microglia 127127
micromechanics PS 08-06
micropet PS 01-06
micropet/ct PL 08-10-02
microscopy PS 05-05103138139
microviscosity 138
mid-infrared PS 22-06
middle cerebral artery occlusion 102
minflux PS 22-06
mitochondria 130
mitosis PL 08-10-02
mitoxantrone PS 06-05
mn2+ alternatives to gd3+ 107
modeling 127
models of sterile inflammation 105
moderate severity stroke model 128
molecular design PS 05-07
molecular fluorescence guided imaging PS 23-07
molecular imaging PS 08-07100104104114115117118
molecular modeling 127
molecular pet imaging PS 18-06
molecular rotors 138
molecular vectors 118
molecular-targeted PS 08-02
monoclonal antibodies #631
monocytes 105
monte carlo 118138
monte carlo simulations 136
morphometry 102
motion compensation PS 02-02
motion correction PS 21-02139
motor task PS 23-02
mouse 103
mouse model PS 05-07129129
mpi 126
mpo PS 21-07
mr-angiography PS 05-07
mri PS 01-06#634PS 05-07PS 23-03PS 23-04PS 23-04PS 08-04PS 08-04PS 21-07PS 21-03PS 21-03PS 21-03PS 09-07#127PS 09-03100101101101101102106106118118119119127127127128129129129133133133134134134134134134134139
mri cas 107
mri contrast agent 107
mri contrast agents 106125134
mri contrastagent 134
mri probes PS 08-04
mri signal amplification 134
mri-guided therapy 101
mri/pet dual probes 106
mrs PS 08-04PS 08-03105118
mrs and mri PS 23-03
mrsi 133133137
msi PS 24-02
msot PS 04-05PS 08-03117
multi modality imaging 137
multi-atlas 103
multi-diameter single fiber spectroscopy / single fiber fluorescence (mdsfr/sff) PS 09-07
multi-modal imaging #634PS 08-03
multi-pinhole spect 115
multidrug resistance 120
multimodal 106
multimodal imaging PS 08-04PS 08-03#92#84PL 08-10-03100100106106120139
multimodal microscopy #624
multimodality 137
multimodality imaging 101
multiphoton microscopy 138
multipinhole spect 115115115
multiple sclerosis PS 05-04102129
multiplexed imaging 114
multiplexing PS 08-07
multispectral PS 23-07PS 09-07
multispectral optoacoustic tomography PS 08-06
myelin 102129
myocardial imaging 115
myocardial infarction 105130130130
myocarditis 130
myocardium PS 23-04
nafld 133133
nano-carriers 101
nano-radiomaterials #40
nanobodies PL 08-10-03126126
nanobody PS 05-03PS 05-03
nanoceramics 106
nanodiamonds PS 06-05100
nanodroplets PS 06-05
nanofluorides PS 08-04
nanoluc complementation PS 08-02
nanomedicine PS 06-03PS 21-07#40125
nanomedicines 125
nanomicelles PS 08-04
nanomotors PS 05-04
nanoparticle PL 08-10-03PL 08-10-02
nanoparticle delivery 120
nanoparticle labeling 106
nanoparticles PS 08-04106106119135
nanophosphor 136
nanovesicles 114
nash PS 21-07105
near infrared 114114138
near infrared fluorescent molecular endoscopy PS 09-07
near infrared optical tomography 139
near-infrared fluorescence PS 05-03132132
near-infrared fluorescence imaging 132
near-infrared fluorescent dye 114
near-infrared imaging 104
near-infrared probe PS 06-05
necrosis PS 06-03
necrosis imaging 113
neoadjuvant therapy PS 09-07
neocardina 138
network analysis 127
network stabilization 128
neuro-imaging 103
neurobehavior 128
neuroblastoma PS 09-07
neurodegeneration 103
neuroimaging PS 01-06PS 06-04102102103
neuroinflammation PS 01-06PS 09-03127128
neuron cells 103
neuronal cell cultures 128
neuropeptides 129
neuroprotection PS 21-03128
neuroradiology PS 01-06
neurotensin PS 08-02119119
neurovascular coupling PS 23-02
neutrophils 105
nevi 100
new tracer 119
nir-fluorescent tracers 114
nir-ii contrast agent PS 08-07
nirf PS 23-07#151
nitrogen-vacancy centers PS 06-05
nitrosative stress 130
nk1 receptors 128
nmrd PS 08-04
nodal metastasis PS 23-07
non-absorbable sutures 104
non-invasive PS 09-02
non-invasive imaging PS 09-03129
non-linear imaging 138
nonhuman primate 131
novel theranostic probes 134
nsclc 119
ntr PS 08-07
ntsr1 100
nuclear imaging 105132
nuclear medicine PS 22-05
nuclear morphology 118
numerical simulation PS 05-05
oatp PS 06-05
obesity PS 21-03
occupational exposure PS 05-05
olinda 118
oncocardiology 130
oncology 101
onolytic virus PS 08-02
optical 139
optical clearing 139
optical control PS 05-07
optical imaging PS 05-05PS 08-02#84100106114114114136136138138
optical imaging fluorophores 101
optical imaging of infections 114
optical imaging probe 132
optical molecular imaging PS 08-02
optical projection tomography 138
optics PS 05-05
optimization PS 05-05
opto-acoustic 100
optoacoustic PS 06-03PS 08-03PS 09-02
optoacoustic bio-imaging PS 04-05
optoacoustic imaging PS 23-05104133
optoacoustic microscopy PS 22-06
optoacoustic techniques 133
optoacoustic tomography PS 06-03103117129
optoacoustics PS 08-07PS 08-06104117117117
optoacpustic imaging PS 09-02
optogenetics PS 09-03PS 09-03
organic chemistry PS 05-04
orthotopic glioblastoma model 120
orthotopic mouse model 125
orthotopic xenograft PS 05-03
osem PS 01-03
osimertinib 119
osteoporosis 135
ovalbumin 126
ovarian cancer PL 08-10-03PL 08-10-02101125
ovarian transplantation 114
oxidative stress 128130
oxidized low-density lipoprotein 104
oxygen 133
oxygen partial pressure measurment 138
oxygenation 117
oxygenation-sensitive mri 137
p-selectin PS 21-07PS 09-02105
p2y12 127
p2y12 receptor 127
p301s 128
paclitaxel 134
paediatric 118
pain chronification 127
palmitic acid 114
pan-cancer 100
pancreas PS 08-02
pancreatic cancer PS 08-02PS 08-02PL 08-10-03100100119120132
pancreatic cyst neoplasm 100
pancreatic ductal adenocarcinoma PS 06-03
paracest 107134
parahydrogen PS 23-03
parallel transmit rf coil arrays PS 23-03
paramagnetism PS 06-05
parametric mapping PS 19-03
parathyroid gland 132
parathyroid hyperplasia 113
parkinson's disease PS 01-06PS 23-02129
parkinson`s disease PL 08-10-01
parp 100135
partial volume effect correction 139
partial wave spectroscopy PL 08-10-03
pathogenesis PS 05-07
pathomechanism 130
patient-derived xenograft PS 05-03
patient-derived xenografts PS 23-05
pd-l1 PS 18-06PS 05-03
pdac 119133137
pdac cancer PL 08-10-03
peg-spacer 119
pept-in 131
perfluorocarbons PS 23-04
perfusion 113117132
peripheral arterial disease 133
peripheral vascular disease 133
peristaltism 120
permeability 137
pertussis PS 05-07
pertussis toxin 102
perylene diimide PS 06-05
pet PS 01-03PS 01-06PS 22-05PS 22-02PL 08-10-01#634PS 23-05PS 05-03PS 05-04PS 05-04PS 06-04PS 06-03PS 06-03PS 23-04PS 08-03PS 08-03PS 21-07PS 21-07PS 08-02PS 09-07PS 09-03PL 08-10-03PL 08-10-03100100102104104106113113118119119120127127129129130130131133135135PS 24-02
pet ct 135
pet imaging PS 01-06PL 08-10-01PS 05-03PS 05-04PS 05-04PS 23-02PS 23-04PS 21-07PS 09-07100113119119119127129131132133133
pet imaging. PS 05-04
pet infection imaging 131
pet metallomics PL 08-10-02
pet scan 103
pet tracer 129
pet-ct PS 05-07PS 08-03131135
pet-mr PS 21-02
pet-mri PS 05-03PS 21-03129
pet/ct PS 01-03PS 01-07PS 08-07100104105115120126
pet/ct imaging PS 21-07
pet/ct-imaging PS 05-03
pet/fmri PS 23-02
pet/mr PS 01-03PS 21-02118
pet/mri PS 01-07PS 08-03PS 08-02#303105106106115
pet/spect PL 08-10-03PL 08-10-03
pfc-nanoemulsions 130
pfcs 105
ph imaging 107118137
ph mapping 107
ph sensor 134134
phantom PS 09-02115117
phantoms 117
pharmacokinetic 118
pharmacokinetics PS 06-03135
pharmacology 103
phase contrast imaging PS 21-02
phase i 126
phase mapping PS 21-03
phase retrieved tomography 138
phase-contrast 103
phasecontrast PS 08-02
phosphine 113
phospolipids PS 08-04
photo-cidnp 107
photo/optoacoustic 126
photoacoustic PS 06-05PL 08-10-03114114117139
photoacoustic imaging PS 06-05PS 08-06PS 09-02117136
photoacoustics PS 09-02104117117133
photocage 136
photochemistry PS 05-04
photocontrollable proteins PS 08-07
photodynamic therapy PS 06-03PS 21-07125125
photoimmunotherapy PS 23-05
photon counting PS 02-02
photon-counting 116
photon-counting micro-ct 116
photopharmacology PS 05-07
photoradiolabelling PS 05-04
photosensitizer 125
pituitary adenoma PS 23-07
pla-nanoparticles 134
placenta 133
plaque burden 104
plasmodium PS 05-07
platform #151
plga 138
polarization second harmonic generation 100
polarization sensitive shg 129
polidentate chelators 113
poly-histidine 104
polychromatic 116
polymer contrast agent 107
polymer-in-oil material PS 09-02
polymeric nanoparticles PS 08-04
polymersomes 101
polypept(o)ide stars 125
polypyrrole nanoparticles 136
porphyrins 113
positon emission tomography 102
positron emission tomography PS 01-06PS 01-07PS 08-07#84105113119120127129130
postoperative hypoparathyroidism 132
pre-clinical 128
pre-clinical imaging 103
pre-resonance PS 05-05
precision medicine PS 23-05125
preclinical PS 01-07115118118120133133
preclinical computed tomograpy 118
preclinical imaging PS 05-05PS 06-05106115
preclinical mri 101
preclinical pet PS 08-06PS 21-02103
preclinical pet insert PS 21-02
preclinical spect 115115
preclinical studies 127
preclinical trials 125
pretargeting PL 08-10-03104
primate PS 23-02
probe chemistry 107
product penetration 138
prohance 107
projections 138
prostae & pancreas 107
prostate cancer PS 23-07PL 08-10-02100100101119
proste cancer 100
protein radiolabelling 126
protein synthesis rate 102
protein tau 128
proteins PS 09-02
proton therapy PS 06-05
prrt 101
psma PL 08-10-02100100101106119
pulmonary airways PS 21-02
pulmonary arterial hypertension PS 23-04
pulmonary fibrosis 116
pulmonary hypertension 133
pyclen derivatives 134
q175 mouse model 102
quantification PS 08-06PS 08-02115118
quantitation 132
quantitative mri PS 19-03102137
quantitative nanomechanics 120
quantitative photoacoustic tomography 117
quantitave 116
quasi-periodic patterns 102
rabbit 115
radiation-induced nucleation theory PS 06-05
radio-contrast agents 116
radioactive labeling 113
radiochemistry PS 05-04PS 05-04PS 08-07135135
radiofluorination 113
radiofrequency ablation PS 09-02
radiolabeling 106119
radiometal 113
radiomics 104118118
radionuclide PS 23-07
radionuclide therapy 101101
radiosynthesis 135
radiotoxicity 125
radiotracer PS 05-07127135
radiotracers PS 01-06
raman mapping 126
raman spectroscopy 138
range verification PS 06-05
rasp PS 09-02
rat PS 23-02PS 08-03129
ratiometric mri method 107
ratiometry PS 08-04
rats 118
real-time mri PS 19-03
recombinant proteins 104
reconstruction 118
reconstruction algorithm 115
recovery 102
redox-sensitive 114
regularization PS 05-05
remote ischemic conditioning PS 21-03
remyelination 127
renal PS 23-03
repeated social defeat 103
reporter gene 129
resistance PL 08-10-03
resolution modeling PS 01-03
respiratory system 104
response to therapy PS 06-03
responsive agents 107
responsive contrast agent 107
resting state PS 23-02PS 08-03103103127
resting state fmri PS 23-02PS 08-03128
resting state functional mri 102
retention 107
retina 129
reward system 127
rf coil design 137
rhenium 113
rheumatoid arthritis PS 21-07
rhodobacter 126
riboflavin 125
rnaseq PL 08-10-02
rodent 103
ros PS 21-07113
rotenone mouse model of parkinson's disease 102
rs-fmri 127
rsfmri 102
s. aureus 130131
safir PS 21-02
sah 128
sample collection PL 08-10-02
sarcoma PS 23-07
scaffold characterization 129
scan protocol optimization 100
scinitgraphic 135
scintillator crystal 115
segmentation 103118
selective targeting 106
semiquantification PS 08-06
sensory stimulation 103
serotonin transporter PS 23-02
shift reagent PS 06-04
short term modulation PS 23-02
shortwave infrared fluorescence PS 05-05
siderophore 131
siderophores 131131
sigma-1 receptor 120
silica nanoparticles 106
silicosis mouse model 105
simulation 138
simulations 118
simultaneous 3pef and 2pef microscopy 103
simultaneous pet/ct-uui system 139
simultaneous pet/mri 106
single molecule localization PS 22-06
single molecule tracking PS 22-06
single voxel 1h spectroscopy 128
single-domain antibody 132
site-specific PS 05-03#151
site-specific bioconjugation 104
skeletal muscle recovery 118
skin cancer PL 08-10-02
sliding window analysis 102
slow waves PS 09-03PS 09-03
small animal PS 01-07
small animal mri 137
small animal pet PS 21-02
small molecule donor 136
small molecule targeting moieties 114
small molecules 105
small-animal imaging 115
small-animal spect 115
smart contrast agent 107
smart probes 107
smartphone ophthalmoscope 103
smartprobe 136
smartprobes 114
sodium PS 23-03
somatostatin receptor PS 23-07
sonopermeation 125
sonoporation 101
spatial statistics 120
spatial transcriptomics 103
spect PS 01-03PS 08-07106106113113135
spect/ct PS 01-03PS 08-03105118120
spect/ct imaging 135135
spect/mri PS 05-07
spectiq phantom 115
spectroscopic ct PS 08-03
spectroscopy PS 06-04PS 09-02
speed-of-sound 117
spheroids PL 08-10-03PL 08-10-03101
spill-in effect PS 08-06
spim 138138
spinal cord injury 102129
spion 106
spions 106
spline 118
spm PS 08-06
spondyloarthritis 105
stability 107
standardisation 117
staphylococcus aureus PS 05-07
stem cells PS 06-05106106
stent graft infections 131
stimulated raman scattering PS 05-05
strain PS 08-06
stroke PS 06-04PS 21-03PS 21-03102103128128
stroke model PS 21-03
stroke-induced hyperconnectivity 128
structure-activity relationships 135
subarachnoid haemorraghe 128
subcutaneous tumor xenografts 139
sultone 119
super resolution PS 06-05
super resolution in cardiac pet PS 21-02
super resolution optical microscopy PS 22-06
super-resolution microscopy 131
superparamagnetic nanoparticles 106
superresolution PS 09-03
supra molecular probes 134
surgical margin assessment 138
susceptibility-weighted imaging PS 21-03
sv2a 127129
swir imaging PS 08-07
synaptic density 102129
synaptique density 127
synchrotron imaging 116
synchrotron radiation PS 21-02PS 21-02
synchrotron xrf PS 23-04
synthesis PS 06-05
synthesis and characterization 136
synuclein 116
system xc- PS 08-07
t-cell 105
t-cell lymphoma PS 06-04
t1 contrast 107
t1-mri #40
t1-weighted 3d mr 128
takotsubo syndrome 130
tam 126
target-to-background ratio (tbr) PS 08-06
targeted 106
targeted alpha-particle therapy 101
targeted drug delivery PS 23-03125
targeted hyperthermia PS 23-03
targeted imaging 135
targeted nanobubbles 114
targeting PS 08-04106134
tau PS 01-06PS 21-03
tc-99m 130
tca cycle 137
technetium 126
technetium-99 113
technetium-99m 135
technical validation PS 09-02
temporal lobe epilepsy 102
tetrazoles PS 05-04
tgf-beta PS 18-06
thalamus 127
thallium 135
thallium-201 125
theranostic 125
theranostic agents 106
theranostic probes 101
theranostics PS 22-05PS 05-07PL 08-10-03106125125
therapeutic biologicals #631
therapy 128
therapy monitoring PS 09-02
thermogenic activator PS 06-04
thermosensitive liposome 101
third harmonic generation 100
third harmonic generation (thg) 138
thn201 127
thp 135
thrombectomy PS 21-03
thrombosis PS 23-04
thyroid cancer PS 05-03PS 23-07101
thyroid surgery 118
time-lapsed tomography PS 01-07
time-resolved near-infrared spectroscopy 138
tissue distribution 115
tissue implants PS 08-04
tissue-mimicking material PS 09-02
tof-kem 118
tof-pet 115118
tof-sims 138
tolcapone 128
toll-like receptors 102
tomographic microscopy 138
tomography PS 08-02117117
translational 118132
translational imaging PS 21-03
translational research 116
transthyretin 128
transverse electron microscopy 106
treatment response PS 06-03
trifluoromethylation 135
trimodal nanosystems 106
tris (8-hydroxyquinolinato) gallium (iii) 101
tsne PS 08-03
tspo PS 08-06130132
tumor 126
tumor acidosis #303107
tumor imaging 119
tumor invasion PS 23-05
tumor markers 132
tumor microenviroment 139
tumor microenvironment PS 23-05PS 23-05120125
tumor microenvironment heterogeneity 120
tumor microenvironment ph PS 08-07
tumor profil 120
tumor targeting PS 06-03
tumor-associated macrophages 126
tumor-associated-macrophage 126
tumor-homing phagocytes PS 21-07
tumors PS 05-03
tumour PS 23-03PL 08-10-02118
tumour micro environment 120
tumour microenvironemnt PS 06-04
tumour vascularisation PL 08-10-02
tuning photophysical properties 136
turbid media PS 05-05
u-spect5 e-class 115115
ucb-h 102
ultra-high field mri PS 23-03
ultrafast imaging PS 09-03
ultrafast ultrasound 120
ultrafast ultrasound imaging 130
ultrasmall nanoprobes 106
ultrasound #634PS 05-03#127PS 09-03PS 09-02PS 09-02101117117
ultrasound image processing 100
ultrasound imaging 132
ultrasound molecular imaging PS 21-07PS 09-02
ultrasound therapy 101
ultrasound-guided injection PL 08-10-03
ultrasounds PS 21-03PL 08-10-03
upar 100
upconversion 106
uptake 101
usmb 125
uspio PS 09-07
validation 118
vanco-800cw 114
vap-1 130
vascular PS 21-03
vascular disorder PS 05-05
vascular impairment 102
vascular permeability 134
vasculature PS 23-05
vasoreactivity 137
vessels PL 08-10-02
vevolazr-x PL 08-10-03125
vhh PS 08-07
viability PS 23-04
voxel-by-voxel analysis PS 08-03
water-soluble aza-bodipy PS 08-07
western diet PS 08-03
white matter 127
white matter hyperintensities 118
whole body PS 01-07
whole-body 3d 137
whooping cough PS 05-07
x-nuclei 137
x-ray PS 08-02
x-ray computed tomography PS 21-02
x-ray energy 118
x-ray imaging 118
x-ray tomography 103116
xenograft 119
xlf 116
xten 113
zebrafish PS 21-02116
zinc mapping 134
zinc sensors 107
zirconium-89 PS 05-04106#631
zirconium[89] PS 05-07
zymonic acid 137
µct 105133
µpet 133
µspect 133
α1-microglobulin 101
α4β2 nicotinic acetylcholine receptor 102
fluorescence microscopy 106